Since our control cohort consisted predominantly of Caucasian individuals (Table 1), we aimed to ensure that the observed significant difference in number of FHR1-deficient individuals was not driven by the ethnic diversity of our SLE cohort. The gene discussed is CFHR1; the disease is systemic lupus erythematosus.